ArticleOncoimmunology2026

Sequential axitinib and survivin vaccination unlock curative PD-1 immunotherapy in renal carcinoma.

Fanny Méjean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.